Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.3.3, was added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 elements were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:05:31.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2; Removed Revision: v3.2.0 from the history.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:47.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A site-wide government funding notice banner appears, indicating that information may not be up to date and that operations may be affected; it directs users to cc.nih.gov for operating status and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:14:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Updated study status is shown on the history page. Additional sections such as Adverse Events and Outcome Measures have been revised, reflecting ongoing updates to the NCT04098068 trial record.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:51.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    11%
    Check dated 2025-10-06T06:55:52.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:28:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.